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Classical swine fever (CSF), a highly contagious disease of pigs caused by the classical swine fever virus
(CSFV), can lead to important economic losses in the pig industry. Numerous CSFV isolates with various
degrees of virulence have been isolated worldwide, ranging from low virulent strains that do not result
in any apparent clinical signs to highly virulent strains that cause a severe peracute hemorrhagic fever
with nearly 100% mortality. Knowledge of the molecular determinants of CSFV virulence is an
important issue for effective disease control and development of safe and effective marker vaccines.
In this review, the latest studies in the ﬁeld of CSFV virulence are discussed. The topic of virulence is
addressed from different angles; nonconventional approaches like codon pair usage and quasispecies
are considered. Future research approaches in the ﬁeld of CSFV virulence are proposed.
& 2013 Elsevier Inc. All rights reserved.Introduction
Classical swine fever virus (CSFV), the infectious agent of
classical swine fever (CSF), can cause important economic losses,
representing a constant and serious threat for the pig industry
(Edwards et al., 2000; Vandeputte and Chappuis, 1999). The
disease can manifest as acute hemorrhagic fever with respiratory,
gastrointestinal and neurological symptoms resulting in high
mortality rates, as a chronic disease with atypical symptoms, or
even remain mostly unapparent (Kaden et al., 2000). Besides host
factors like the age and general health status of the animals, it is
mainly the virulence of the CSFV isolate that determines disease
severity (Moennig et al., 2003). Virulence of a virus can be deﬁned
as ﬁtness advantage or as the ability of the virus to cause clinical
and pathological symptoms in a susceptible host. In some reports
virulence was related to cell killing in vitro (Herrera et al., 2007).
In this review, virulence of CSFV is deﬁned as the ability of the
virus to cause clinical and pathological signs in pigs. The virulence
of CSFV isolates ranges from avirulent to highly virulent with up
to 100% mortality (Kaden et al., 2000). Avirulent vaccine strains
were obtained from highly virulent strains by attenuation
through multiple passaging in cell culture or in non-natural hosts
such as guinea pigs and rabbits. One example is the live vaccine
C-strain (Chinese strain) ‘‘Riems’’ (Kaden et al., 2000, 2004; Kaden
and Lange, 2001).ll rights reserved.
eifer).CSFV possess a single positive-strand RNA genome of approxi-
mately 12,300 nucleotides ﬂanked by 5’ and 3’ non-translated
regions (NTR) (Meyers and Thiel, 1996). The large open reading
frame encodes typically a polyprotein of 3898 amino acids that
undergoes co- and post-translational processing by cellular and
viral proteases (Meyers and Thiel, 1996). The polyprotein proces-
sing generates the four structural proteins C, ERNS, E1, and E2 and
the eight non-structural proteins Npro, P7, NS2, NS3, NS4A, NS4B,
NS5A, and NS5B (Ru¨menapf et al., 1993; Tautz et al., 1997; Thiel
et al., 1991).
Several groups studied the molecular biology of CSFV extensively
with the aim of identifying molecular determinants of virulence
(Fernandez-Sainz et al., 2009, 2010; Gladue et al., 2012; Leifer et al.,
2011; Tamura et al., 2012; Risatti et al., 2005a, 2005b; Risatti et al.,
2006, 2007; Sainz et al., 2008; Van Gennip et al., 2004). Different
aspects are discussed regarding their inﬂuence on and correlation
with CSFV virulence. This review shall help to consider different
molecular viewpoints in the context of virulence.Towards deﬁning viral genetic determinants of CSFV virulence
Attenuation of CSFV through serial passages in non-natural hosts
Avirulent vaccine strains are derived from highly virulent strains
by attenuation through multiple passages in cell culture or non-
natural animal hosts. One example is the ‘‘GPE-’’ vaccine [NCBI:
D49533] that was derived from the strain ‘‘ALD’’ [NCBI:D49532].
With the aim of identifying the mutations responsible for the loss of
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completely sequenced (Ishikawa et al., 1995). In this study, 225
nucleotide differences spanning the whole genome were found. Six of
these differences were located in the non-coding regions. As muta-
tions in the NTR of hepatitis C virus are responsible for the loss of
virulence (Friebe and Bartenschlager, 2002), it was postulated that the
exchanges in the NTR of strain ‘‘ALD’’ may also be relevant concerning
virulence. However, no conclusive statements on the involvement of
speciﬁc nucleotide and amino acid exchanges in attenuation of the
‘‘GPE-’’ strain could be drawn.
Gain of pathogenicity by passaging the ‘‘GPE-’’ vaccine strain in pigs
Under ﬁeld conditions, the ‘‘GPE-’’ vaccine virus is not trans-
mitted. Artiﬁcial serial passages of the attenuated ‘‘GPE-’’ vaccine
strain in pigs by injection of infected tonsil homogenates resulted
in the recovery of a pathogenic virus after 11 passages (Tamura
et al., 2012). Sequence analyses revealed one exchange in the E2
protein and two exchanges in the NS4B protein. By introducing
these exchanges into the ‘‘GPE-’’ genome using reverse genetics, it
was demonstrated that these three exchanges were responsible
for the regaining of pathogenicity. While the exchange in the E2
protein may inﬂuence viral entry and release, the exchanges in
the NS4B protein enhanced the replication efﬁciency in porcine
cells. Evidences from other studies on the potential involvement
of E2 and NS4B in virulence are discussed below. The study of
Tamura and colleagues is the ﬁrst that identiﬁed speciﬁc amino
acid sequences of CSFV related to virulence based on gain of
pathogenicity. It is postulated that the recovery of virulence is due
to re-adaptation of the ‘‘GPE-’’ virus to its original host, the pig.
The process of virus adaptation involves probably both genome
mutation and selection of sequences from the quasispecies
population. This is underlined by the ﬁndings that exchanges in
the viral NS4B protein found after several ‘‘GPE-’’ passages in pigs
were already present as a minor quasispecies in the original
‘‘GPE-’’ vaccine. From these experiments it could not be concluded
whether these genome positions are universal CSFV virulence
determinants.Codon and codon pair usage are not related to virulence.
It is well established that differences in codon usage inﬂuence
protein expression (Gouy and Gautier, 1982). In addition, the
codon pair usage was found to inﬂuence virulence of poliovirus
and inﬂuenza virus, for which attenuation was generated by
artiﬁcially modifying the codon pair bias. This was referred to
as de-optimization of the codon pair usage (Coleman et al., 2008;
Mueller et al., 2010). In case of CSFV, no remarkable differences in
codon usage related to virulence were observed (Tao et al., 2009).
This is supported by the observation that codon usage of RNA
viruses is related to the host (Su et al., 2009). Comparative
analyses of the codon pair usage of highly, moderately, and
avirulent CSFV strains did not reveal any direct correlation
between codon pair usage and virulence either (Leifer et al.,
2011). Instead, it was observed that differences in codon pair
usage of CSFV isolates cluster the strains into genotypes, similar
to the way primary nucleotide sequence analysis and codon
usage do.
A possible role of quasispecies distribution in virulence
Another aspect that has never been investigated in the context
of CSFV virulence so far is the role of the quasispecies distribution
of the viral RNA. Deep sequencing facilities and accompanying
analysis software have made in-depth quasispecies analysespossible. A potential role of the quasispecies composition of CSFV
isolates in inﬂuencing their virulence should be considered, as it
had already been determined to affect the virulence of other
viruses like foot-and-mouth disease virus (Ojosnegros et al.,
2010a, 2010b). Several reports show the occurrence of different
quasispecies in CSFV isolates (Kiss et al., 1999; Leifer et al., 2010a,
2010b). In order to further investigate this, the quasispecies
composition of the E2 und NS5B encoding genes of highly and
low to moderately virulent strains was analyzed. Here, differences
in the nucleotide variability and quasispecies entropy were
observed (Leifer et al., this issue). The highest genome diversity
was found in the highly virulent strains ‘‘Brescia’’ and ‘‘Koslov’’
compared to the low and moderately virulent isolates ‘‘Paderborn’’,
‘‘Hennef’’, and ‘‘Uelzen’’. From these limited preliminary data it is not
possible to state whether the higher genome variability observed in
highly virulent isolates does contribute to the virulence phenotype. As
severe clinical signs were observed after infections with CSFV
‘‘Eystrup’’ and ‘‘Brescia’’ derived from cDNA which have a rather
homogeneous genome composition (Mayer et al., 2003; Risatti et al.,
2005), a high quasispecies diversity is unlikely to be a virulence
determinant per se, but its potential involvement in inﬂuencing
virulence cannot be excluded yet. For conclusive argumentation,
further in depth analyses are required.
In vitro cytopathogenic CSFV are attenuated
In some studies, virulence is related to the ability to kill cells
in vitro (Herrera et al., 2007). Cytopathogenicity of pestiviruses in
cell culture is linked to high amounts of free NS3 protein resulting
from more effective cleavage of the NS2 and NS3 proteins from
the NS2-3 precursor protein. For CSFV, cytopathogenicity is a
phenotype that has only rarely been observed in cell culture with
natural occurring isolates (Aoki et al., 2001; Kosmidou et al.,
1998). Nevertheless, several cytopathogenic CSFV were generated
artiﬁcially. In particular, insertion of the NS2 cofactor Jiv-90 for
enhanced NS2-3 cleavage resulted in a virus that was attenuated
in pigs (Gallei et al., 2008).Attenuation of CSFV by knocking out glycosylation sites of the
envelope glycoproteins
Glycosylation of viral structural proteins is important for the
virus life cycle (Doms et al., 1993; Hanna et al., 2005; Meyers
et al., 2007; Risatti et al., 2005; Shi and Elliott, 2004; Shi
et al., 2005; Van Gennip et al., 2004). Five to six putative
N-glycosylation sites and one O-glycosylation site have been
predicted for the E2 protein of CSFV (Moormann et al., 1990;
Risatti et al., 2007). Five of these N-glycosylation sites in E2 are
highly conserved among CSFV isolates. Only the isolates ‘‘CSF39,’’
‘‘LPC,’’ and ‘‘Penevezys’’ show differences at the ﬁrst and fourth
N-glycosylation sites. Glycosylation is obviously necessary for the
expression of virulence, but since the N-glycosylation sites are
conserved among highly virulent and avirulent vaccine strains
they are very unlikely represent virulence determinants for CSFV
on their own. The sixth N-glycosylation site of the E2 protein is
slightly more variable.
Seven N-glycosylation sites are described for the ERNS protein
(Sainz et al., 2008) and three for the E1 protein (Fernandez-Sainz
et al., 2009). All these glycosylation sites are highly conserved
among CSFV isolates, independent of their virulence. Only the
N362 (asparagine) in the E
RNS is not found in the avirulent vaccine
strain ‘‘GPE-,’’ where the asparagine is replaced by a serine (Leifer,
unpublished data).
As shown by Risatti et al. (2007), mutation of the E2
N-glycosylation sites can result in less virulent phenotypes. The
same results were obtained when mutating N-glycosylation sites
in the ERNS and E1 protein of CSFV (Fernandez-Sainz et al., 2009;
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viral proteins is crucial for viral replication (Ansari et al., 2006;
Deshpande et al., 1987; Gupta and Brunak, 2002; Horimoto and
Kawaoka, 1994; Hulse et al., 2004). A lack of N-glycan chains can
lead to protein misfolding, causing aggregation in the ER or
degradation (Indyk et al., 2007; Parodi, 2000; Trombetta, 2003).
Furthermore, these exchanges introduced experimentally might
alter the protein structure independent of its glycosylation status,
and may thereby inﬂuence virus growth and virulence.
A selective pressure analysis in the E2 protein turns up
interesting results. At amino acid positions 72 and 75 surrounding
the O-glycosylation site, a positive selection was observed (Tang
and Zhang, 2007). These ﬁndings were conﬁrmed by Wu et al.
(2010) who tried to determine the correlation between virulence
and evolution of the E2 protein in CSFV isolates. The polyprotein
sequences of the O-glycosylation site in the E2 protein differ
slightly among CSFV isolates. Changing the O-glycosylation site of
the highly virulent strain ‘‘Brescia’’ (Risatti et al., 2007) did not
alter its virulence. But investigations in this study were limited to
replacing the amino acid proline with alanine. Proline is mainly
found in avirulent and moderately virulent strains at the
described position, while in highly virulent strains the proline is
replaced by lysine. This region differs in up to three amino acids
when comparing highly virulent strains to low virulent strains.
Furthermore, O-glycosylation takes place at serine or threonine,
whereas a nearby proline can alter the efﬁciency of glycosylation
(Veluraja et al., 2001). The protein structure has been described as
being important for efﬁcient O-glycosylation (Aubert and
Loucheux-Lefebvre, 1976; Dahms and Hart, 1986; Fiat and Jolles
et al., 1980). In order to ﬁnd out more about the O-glycosylation
of the E2 protein and its role in virulence, replacing the region
surrounding the O-glycosylation site of a low virulent strain by
the sequence found in a highly virulent strain might be insightful.The potential role of selected individual viral proteins in CSFV
virulence
Different viral proteins of CSFV were associated with virulence.
The Npro protein possesses two different functions: an auto-
proteolytic function as protease (Ru¨menapf et al., 1998; Stark
et al., 1993), and an inhibitory effect on the interferon (IFN)
induction pathway (Bauhofer et al., 2007; Gil et al., 2006; Hilton
et al., 2006; Horscroft et al., 2005; La Rocca et al., 2005; Ruggli
et al., 2003, 2005, 2009) by mediating the degradation of the
interferon regulatory factor 3 (IRF3). Animal experiments showed
that CSFV mutants missing the Npro protein were attenuated
(Mayer et al., 2004; Tratschin et al., 1998), whereas mutations
in the Npro protein abolishing IRF3 degradation did only slightly
alter virulence (Ruggli et al., 2009). This indicates that Npro is not
responsible for the different degrees of virulence among CSFV
isolates. More likely, inhibiting the IFN response via the IRF3
pathway may help the virus to overcome the initial innate
immune defense of the host. It may also inﬂuence the persistence
of the virus in the host as suggested for BVDV (Meyers et al.,
2007). Furthermore, an interaction of Npro with IRF7 was reported
(Fiebach et al., 2011). This manipulation of the IRF7 function is
another way for CSFV to circumvent the host’s innate immune
defense. But again, this is probably similarly regulated in the
different CSFV isolates, independent of virulence.
The structural glycoproteins ERNS, E1, and E2 are parts of the viral
envelope membrane and are essential for replication, virus attach-
ment, and entry (Ru¨menapf et al., 1993). In addition, the ERNS protein
possesses ribonuclease activity (Hulst et al., 1994; Langedijk et al.,
2002; Schneider et al., 1993). Mutations that abrogate the ribonu-
clease activity led to virus attenuation (Meyers et al., 1999). For
BVDV a role of ERNS in the control of IFN-b activation is described(Iqbal et al., 2004). The ERNS proteins are found as homodimers on
the surface of the virion (Thiel et al., 1991). This dimerization is not
essential for viral replication and infection (Van Gennip et al., 2005),
but the loss of dimerization causes virus attenuation as well (Tews
et al., 2009). Mutations in the ERNS of strain ‘‘Brescia’’ C1.1.1
combined with adaptive mutations in the E2 protein led to reduced
virulence (Van Gennip et al., 2004).
The E2 protein has also been proposed as a virulence determi-
nant (Risatti et al., 2005, 2006; Van Gennip et al., 2004). E2 is the
most immunogenic protein of CSFV and induces the formation of
neutralizing antibodies, especially against the highly immunogenic
TAV-epitope therein (amino acids TAVSPTTL) (Chen et al., 2010;
Lin et al., 2000; Liu et al., 2006a, 2006b; Zhang et al., 2006).
Replacing the TAV-epitope in CSFV with the corresponding epitope
of BVDV strain NADL resulted in attenuated CSFV mutants (Risatti
et al., 2006). Exchange of the complete E2 protein of the highly
virulent strain ‘‘Brescia’’ with that of a CSFV vaccine strain resulted
in a less virulent phenotype of the chimeric pestivirus (Risatti et al.,
2005). By performing biostatistical analyses of evolutionary pat-
terns within the E2 protein of CSFV, a correlation between adapta-
tion and virulence was considered (Wu et al., 2010). These ﬁndings,
and the ﬁndings made by Tamura and colleagues, point towards a
potential role of the E2 protein in virulence (Tamura et al., 2012).
Besides the E2 protein, the NS4B protein appears to inﬂuence
virulence too. As mentioned above, two amino acid exchanges in
NS4B were involved in the partial recovery of virulence after
artiﬁcial re-adaptation of the ‘‘GPE-‘‘ vaccine virus to pigs (Tamura
et al., 2012). This suggested that the mutations found in E2 and
NS4B of CSFV during this re-adaptation process may act syner-
gistically to inﬂuence pathogenicity in pigs. Importantly also,
NS4B of CSFV harbors a putative Toll/interleukin-1 receptor-like
domain (Fernandez-Sainz et al., 2010). This domain is located
closely to the NS4B mutations identiﬁed above. Mutations in this
domain in the highly virulent ‘‘Brescia’’ backbone resulted in an
attenuated virus, probably by affecting the modulation of the host
immune response. NS4B carries also a nucleoside triphosphatase
motif. This activity is essential for CSFV replication, but there is no
evidence of involvement in virulence yet (Gladue et al., 2011).Conclusions
Viral entry into and release from the target cells, speed of viral
replication, and the ability of the virus to circumvent the host’s
immune responses are critical factors for viral disease outcome.
The E2 protein is involved in viral attachment to the host cells and
the NS4B protein is part of the replication complex. Hence, both
proteins can be related to virulence and pathogenicity. But so far
no universal sequence patterns determining virulence of CSFV
have been reported. Instead, virulence of CSFV is more likely to be
a multigenic feature determined by a complex interplay of several
viral genes or genome regions acting in concert. However, viral
attenuation can easily be obtained in vitro by introduction of
mutations in highly conserved sequence patterns that are neces-
sary for viral replication, as shown in various studies. Further-
more, the quasispecies composition might likely have only a
minor impact on CSFV virulence.Outlook
In former studies, highly conserved molecular sequence pat-
terns essential for viral replication were considered as potential
virulence factors. By mutation of these elements, attenuated
(‘‘defect’’) viruses were created that lack speciﬁc properties,
leading to less virulent phenotypes. Most notably, virulence and
I. Leifer et al. / Virology 438 (2013) 51–5554sequence differences between isolates were not taken into
account. As a prerequisite for determination of virulence factors,
CSFV isolates should be grouped into different classes of viru-
lence/pathogenicity (e.g., avirulent, low to moderately virulent,
and highly virulent). Characteristic and conserved sequence
patterns within these groups should be used as a basis for future
investigations in the ﬁeld of CSFV virulence. Virulence studies
should also consider modifying low virulent isolates by reverse
genetics with the aim of generating viruses of higher virulence to
demonstrate the role of deﬁned genome sequence patterns in
determining virulence. It is also of interest to investigate whether
certain genetic determinants of CSFV virulence may be related to
other Flaviviridae like West Nile fever virus, dengue virus, or
hepatitis C virus.Acknowledgments
This study was supported by the Swiss Federal Veterinary
Ofﬁce (BVET), Grant # 1.10.13.
References
Ansari, I.H., Kwon, B., Osorio, F.A., Pattnaik, A.K., 2006. Inﬂuence of N-linked
glycosylation of porcine reproductive and respiratory syndrome virus GP5 on
virus infectivity, antigenicity, and ability to induce neutralizing antibodies.
J. Virol. 80, 3994–4004.
Aoki, H., Ishikawa, K., Sakoda, Y., Sekiguchi, H., Kodama, M., Suzuki, S., Fukusho, A.,
2001. Characterization of classical swine fever virus associated with defective
interfering particles containing a cytopathogenic subgenomic RNA isolated
from wild boar. J. Vet. Med. Sci. 63, 751–758.
Aubert, J.P., Loucheux-Lefebvre, M.H., 1976. Conformational study of alpha1-acid
glycoprotein. Arch Biochem. Biophys. 175, 400–409.
Bauhofer, O., Summerﬁeld, A., Sakoda, Y., Tratschin, J.D., Hofmann, M.A., Ruggli, N.,
2007. Classical Swine Fever virus Npro interacts with interferon regulatory
factor 3 and induces its proteasomal degradation. J. Virol. 81, 3087–3096.
Chen, N., Tong, C., Li, D., Wan, J., Yuan, X., Li, X., Peng, J., Fang, W., 2010. Antigenic
analysis of classical swine fever virus E2 glycoprotein using pig antibodies
identiﬁes residues contributing to antigenic variation of the vaccine C-strain
and group 2 strains circulating in China. Virol. J. 7, 378.
Coleman, J.R., Papamichail, D., Skiena, S., Futcher, B., Wimmer, E., Mueller, S., 2008.
Virus attenuation by genome-scale changes in codon pair bias. Science 320,
1784–1787.
Dahms, N.M., Hart, G.W., 1986. Inﬂuence of quaternary structure on glycosylation.
Differential subunit association affects the site-speciﬁc glycosylation of the
common beta-chain from Mac-1 and LFA-1. J. Biol. Chem. 261, 13186–13196.
Deshpande, K.L., Fried, V.A., Ando, M., Webster, R.G., 1987. Glycosylation affects
cleavage of an H5N2 inﬂuenza virus hemagglutinin and regulates virulence.
Proc. Natl. Acad. Sci. USA 84, 36–40.
Doms, R.W., Lamb, R.A., Rose, J.K., Helenius, A., 1993. Folding and assembly of viral
membrane proteins. Virology 193, 545–562.
Edwards, S., Fukusho, A., Lefevre, P., Lipowski, A., Pejsak, Z., Roehe, P., Westergaard,
J., 2000. Classical swine fever: the global situation. Vet. Microbiol. 73,
103–119.
Fernandez-Sainz, I., Gladue, D.P., Holinka, L.G., O’Donnell, V., Gudmundsdottir, I.,
Prarat, M.V., Patch, J.R., Golde, W.T., Lu, Z., Zhu, J., Carrillo, C., Risatti, G.R.,
Borca, M.V., 2010. Mutations in classical swine fever virus NS4B affect
virulence in swine. J. Virol. 84, 1536–1549.
Fernandez-Sainz, I., Holinka, L.G., Gavrilov, B.K., Prarat, M.V., Gladue, D., Lu, Z.,
Jia, W., Risatti, G.R., Borca, M.V., 2009. Alteration of the N-linked glycosylation
condition in E1 glycoprotein of Classical Swine Fever Virus strain Brescia alters
virulence in swine. Virology 386, 210–216.
Fiat, A.M., Jolles, J., Aubert, J.P., Loucheux-Lefebvre, M.H., Jolles, P., 1980. Localisa-
tion and importance of the sugar part of human casein. Eur. J. Biochem. 111,
333–339.
Fiebach, A.R., Guzylack-Piriou, L., Python, S., Summerﬁeld, A., Ruggli, N., 2011.
Classical swine fever virus N(pro) limits type I interferon induction in
plasmacytoid dendritic cells by interacting with interferon regulatory factor
7. J. Virol. 85, 8002–8011.
Friebe, P., Bartenschlager, R., 2002. Genetic analysis of sequences in the 3‘
nontranslated region of hepatitis C virus that are important for RNA replica-
tion. J. Virol. 76, 5326–5338.
Gallei, A., Blome, S., Gilgenbach, S., Tautz, N., Moennig, V., Becher, P., 2008.
Cytopathogenicity of Classical Swine Fever virus correlates with attenuation
in the natural host. J. Virol. 82, 9717–9729.
Gil, L.H., Ansari, I.H., Vassilev, V., Liang, D., Lai, V.C., Zhong, W., Hong, Z.,
Dubovi, E.J., Donis, R.O., 2006. The amino-terminal domain of bovine viral
diarrhea virus Npro protein is necessary for alpha/beta interferon antagonism.
J. Virol. 80, 900–911.Gladue, D.P., Gavrilov, B.K., Holinka, L.G., Fernandez-Sainz, I.J., Vepkhvadze, N.G.,
Rogers, K., O’Donnell, V., Risatti, G.R., Borca, M.V., 2011. Identiﬁcation
of an NTPase motif in classical swine fever virus NS4B protein. Virology 411,
41–49.
Gladue, D.P., Holinka, L.G., Largo, E., Fernandez, S., Carrillo, I., O’Donnell, C.,
Baker-Branstetter, V., Lu, R., Ambroggio, Z., Risatti, X., Nieva, G.R., Borca, M. V.,
J.L., 2012. Classical swine fever virus p7 protein is a viroporin involved in
virulence in swine. J. Virol. 86, 6778–6791.
Gouy, M., Gautier, C., 1982. Codon usage in bacteria: correlation with gene
expressivity. Nucleic Acids Res. 10, 7055–7074.
Gupta, R., Brunak, S., 2002. Prediction of glycosylation across the human proteome
and the correlation to protein function. Pac Symp. Biocomput., 310–322.
Hanna, S.L., Pierson, T.C., Sanchez, M.D., Ahmed, A.A., Murtadha, M.M., Doms, R.W.,
2005. N-linked glycosylation of west nile virus envelope proteins inﬂuences
particle assembly and infectivity. J. Virol. 79, 13262–13274.
Herrera, M., Garcia-Arriaza, J., Pariente, N., Escarmis, C., Domingo, E., 2007.
Molecular basis for a lack of correlation between viral ﬁtness and cell killing
capacity. PLoS Pathog. 3, e53.
Hilton, L., Moganeradj, K., Zhang, G., Chen, Y.H., Randall, R.E., McCauley, J.W.,
Goodbourn, S., 2006. The NPro product of bovine viral diarrhea virus inhibits
DNA binding by interferon regulatory factor 3 and targets it for proteasomal
degradation. J. Virol. 80, 11723–11732.
Horimoto, T., Kawaoka, Y., 1994. Reverse genetics provides direct evidence for a
correlation of hemagglutinin cleavability and virulence of an avian inﬂuenza A
virus. J. Virol. 68, 3120–3128.
Horscroft, N., Bellows, D., Ansari, I., Lai, V.C., Dempsey, S., Liang, D., Donis, R.,
Zhong, W., Hong, Z., 2005. Establishment of a subgenomic replicon for bovine
viral diarrhea virus in Huh-7 cells and modulation of interferon-regulated
factor 3-mediated antiviral response. J. Virol. 79, 2788–2796.
Hulse, D.J., Webster, R.G., Russell, R.J., Perez, D.R., 2004. Molecular determinants
within the surface proteins involved in the pathogenicity of H5N1 inﬂuenza
viruses in chickens. J. Virol. 78, 9954–9964.
Hulst, M.M., Himes, G., Newbigin, E., Moormann, R.J., 1994. Glycoprotein E2 of
classical swine fever virus: expression in insect cells and identiﬁcation as a
ribonuclease. Virology 200, 558–565.
Indyk, K., Olczak, T., Ciuraszkiewicz, J., Watorek, W., Olczak, M., 2007. Analysis of
individual azurocidin N-glycosylation sites in regard to its secretion by insect
cells, susceptibility to proteolysis and antibacterial activity. Acta Biochim. Pol
54, 567–573.
Iqbal, M., Poole, E., Goodbourn, S., McCauley, J.W., 2004. Role for bovine viral
diarrhea virus Erns glycoprotein in the control of activation of beta interferon
by double-stranded RNA. J. Virol. 78, 136–145.
Ishikawa, K., Nagai, H., Katayama, K., Tsutsui, M., Tanabayashi, K., Takeuchi, K.,
Hishiyama, M., Saitoh, A., Takagi, M., Gotoh, K., 1995. Comparison of the entire
nucleotide and deduced amino acid sequences of the attenuated hog cholera
vaccine strain GPE- and the wild-type parental strain ALD. Arch. Virol. 140,
1385–1391.
Kaden, V., Lange, B., 2001. Oral immunisation against classical swine fever (CSF):
onset and duration of immunity. Vet. Microbiol. 82, 301–310.
Kaden, V., Lange, E., Fischer, U., Strebelow, G., 2000. Oral immunisation of wild
boar against classical swine fever: evaluation of the ﬁrst ﬁeld study in
Germany. Vet. Microbiol. 73, 239–252.
Kaden, V., Lange, E., Riebe, R., Lange, B., 2004. Classical swine fever virus Strain ‘C’.
How long is it detectable after oral vaccination? J. Vet. Med. B Infect. Dis. Vet.
Public Health 51, 260–262.
Kaden, V., Ziegler, U., Lange, E., Dedek, J., 2000. Classical swine fever virus: clinical,
virological, serological and hematological ﬁndings after infection of domestic
pigs and wild boars with the ﬁeld isolate ‘‘Spante’’ originating from wild boar.
Berl. Munch. Tierarztl. Wochenschr. 113, 412–416.
Kiss, I., Ros, C., Kecskemeti, S., Tanyi, J., Klingeborn, S.B., Belak, S., 1999. Observa-
tions on the quasispecies composition of three animal pathogenic RNA viruses.
Acta Vet. Hung. 47, 471–480.
Kosmidou, A., Buttner, M., Meyers, G., 1998. Isolation and characterization of
cytopathogenic classical swine fever virus (CSFV). Arch. Virol. 143, 1295–1309.
La Rocca, S.A., Herbert, R.J., Crooke, H., Drew, T.W., Wileman, T.E., Powell, P.P.,
2005. Loss of interferon regulatory factor 3 in cells infected with classical
swine fever virus involves the N-terminal protease, Npro. J. Virol. 79,
7239–7247.
Langedijk, J.P., van Veelen, P.A., Schaaper, W.M., de Ru, A.H., Meloen, R.H., Hulst,
M.M., 2002. A structural model of pestivirus E(rns) based on disulﬁde bond
connectivity and homology modeling reveals an extremely rare vicinal
disulﬁde. J. Virol. 76, 10383–10392.
Leifer, I., Everett, H., Hoffmann, B., Sosan, O., Crooke, H., Beer, M., Blome, S., 2010a.
Escape of classical swine fever C-strain vaccine virus from detection by
C-strain speciﬁc real-time RT-PCR caused by a point mutation in the primer-
binding site. J. Virol. Methods 166, 98–100.
Leifer, I., Hoffmann, B., Ho¨per, D., Bruun, R.T., Blome, S., Strebelow, G., Ho¨reth-
Bo¨ntgen, D., Staubach, C., Beer, M., 2010b. Molecular epidemiology of current
classical swine fever virus isolates of wild boar in Germany. J. Gen. Virol. 91,
2687–2697.
Leifer, I., Hoeper, D., Blome, S., Beer, M., Ruggli, N., 2011. Clustering of classical
swine fever virus isolates by codon pair bias. BMC Res. Notes 4, 521.
Lin, M., Lin, F., Mallory, M., Clavijo, A., 2000. Deletions of structural glycoprotein E2
of classical swine fever virus strain Alfort/187 resolve a linear epitope of
monoclonal antibody WH303 and the minimal N-terminal domain essential
I. Leifer et al. / Virology 438 (2013) 51–55 55for binding immunoglobulin G antibodies of a pig hyperimmune serum. J.
Virol. 74, 11619–11625.
Liu, S., Tu, C., Wang, C., Yu, X., Wu, J., Guo, S., Shao, M., Gong, Q., Zhu, Q., Kong, X.,
2006a. The protective immune response induced by B cell epitope of classical
swine fever virus glycoprotein E2. J. Virol. Methods 134, 125–129.
Liu, S., Yu, X., Wang, C., Wu, J., Kong, X., Tu, C., 2006b. Quadruple antigenic epitope
peptide producing immune protection against classical swine fever virus.
Vaccine 24, 7175–7180.
Mayer, D., Hofmann, M.A., Tratschin, J.D., 2004. Attenuation of classical swine
fever virus by deletion of the viral N(pro) gene. Vaccine 22, 317–328.
Mayer, D., Thayer, T.M., Hofmann, M.A., Tratschin, J.D., 2003. Establishment and
characterisation of two cDNA-derived strains of classical swine fever virus, one
highly virulent and one avirulent. Virus Res. 98, 105–116.
Meyers, G., Ege, A., Fetzer, C., von Freyburg, M., Elbers, K., Carr, V., Prentice, H.,
Charleston, B., Schurmann, E.M., 2007. Bovine viral diarrhea virus: prevention
of persistent fetal infection by a combination of two mutations affecting Erns
RNase and Npro protease. J. Virol. 81, 3327–3338.
Meyers, G., Saalmu¨ller, A., Bu¨ttner, M., 1999. Mutations abrogating the RNase
activity in glycoprotein E(rns) of the pestivirus classical swine fever virus lead
to virus attenuation. J. Virol. 73, 10224–10235.
Meyers, G., Thiel, H.J., 1996. Molecular characterization of pestiviruses. Adv. Virus
Res. 47, 53–118.
Moennig, V., Floegel-Niesmann, G., Greiser-Wilke, I., 2003. Clinical signs and
epidemiology of classical swine fever: a review of new knowledge. Vet. J.
165, 11–20.
Moormann, R.J., Warmerdam, P.A., Van der Meer, B., Hulst, M.M., 1990. Nucleotide
sequence of hog cholera virus RNA: properties of the polyprotein encoded by
the open reading frame spanning the viral genomic RNA. Vet. Microbiol. 23,
185–191.
Mueller, S., Coleman, J.R., Papamichail, D., Ward, C.B., Nimnual, A., Futcher, B.,
Skiena, S., Wimmer, E., 2010. Live attenuated inﬂuenza virus vaccines by
computer-aided rational design. Nat. Biotechnol. 28, 723–726.
Ojosnegros, S., Beerenwinkel, N., Antal, T., Nowak, M.A., Escarmis, C., Domingo, E.,
2010a. Competition-colonization dynamics in an RNA virus. Proc. Natl. Acad.
Sci. USA 107, 2108–2112.
Ojosnegros, S., Beerenwinkel, N., Domingo, E., 2010b. Competition-colonization
dynamics: an ecology approach to quasispecies dynamics and virulence
evolution in RNA viruses. Commun. Integr. Biol. 3, 333–336.
Parodi, A.J., 2000. Protein glucosylation and its role in protein folding. Annu. Rev.
Biochem. 69, 69–93.
Risatti, G.R., Borca, M.V., Kutish, G.F., Lu, Z., Holinka, L.G., French, R.A., Tulman, E.R.,
Rock, D.L., 2005a. The E2 glycoprotein of classical swine fever virus is a
virulence determinant in swine. J. Virol. 79, 3787–3796.
Risatti, G.R., Holinka, L.G., Lu, Z., Kutish, G.F., Tulman, E.R., French, R.A., Sur, J.H.,
Rock, D.L., Borca, M.V., 2005b. Mutation of E1 glycoprotein of classical swine
fever virus affects viral virulence in swine. Virology 343, 116–127.
Risatti, G.R., Holinka, L.G., Carrillo, C., Kutish, G.F., Lu, Z., Tulman, E.R., Sainz, I.F.,
Borca, M.V., 2006. Identiﬁcation of a novel virulence determinant within the
E2 structural glycoprotein of classical swine fever virus. Virology 355, 94–101.
Risatti, G.R., Holinka, L.G., Fernandez, S.I., Carrillo, C., Lu, Z., Borca, M.V., 2007.
N-linked glycosylation status of classical swine fever virus strain Brescia E2
glycoprotein inﬂuences virulence in swine. J. Virol. 81, 924–933.
Ruggli, N., Bird, B.H., Liu, L., Bauhofer, O., Tratschin, J.D., Hofmann, M.A., 2005.
N(pro) of classical swine fever virus is an antagonist of double-stranded
RNA-mediated apoptosis and IFN-alpha/beta induction. Virology 340,
265–276.
Ruggli, N., Summerﬁeld, A., Fiebach, A.R., Guzylack-Piriou, L., Bauhofer, O., Lamm, C.G.,
Waltersperger, S., Matsuno, K., Liu, L., Gerber, M., Choi, K.H., Hofmann, M.A., Sakoda,
Y., Tratschin, J.D., 2009. Classical swine fever virus can remain virulent after speciﬁc
elimination of the interferon regulatory factor 3-degrading function of Npro. J.
Virol. 83, 817–829.Ruggli, N., Tratschin, J.D., Schweizer, M., McCullough, K.C., Hofmann, M.A.,
Summerﬁeld, A., 2003. Classical swine fever virus interferes with cellular
antiviral defense: evidence for a novel function of N(pro). J. Virol. 77,
7645–7654.
Ru¨menapf, T., Unger, G., Strauss, J.H., Thiel, H.J., 1993. Processing of the envelope
glycoproteins of pestiviruses. J. Virol. 67, 3288–3294.
Ru¨menapf, T., Stark, R., Heimann, M., Thiel, H.J., 1998. N-terminal protease of
pestiviruses: identiﬁcation of putative catalytic residues by site-directed
mutagenesis. J. Virol. 72, 2544–2547.
Sainz, I.F., Holinka, L.G., Lu, Z., Risatti, G.R., Borca, M.V., 2008. Removal of a
N-linked glycosylation site of classical swine fever virus strain Brescia Erns
glycoprotein affects virulence in swine. Virology 370, 122–129.
Schneider, R., Unger, G., Stark, R., Schneider, S., Thiel, H.J., 1993. Identiﬁcation of a
structural glycoprotein of an RNA virus as a ribonuclease. Science 261,
1169–1171.
Shi, X., Brauburger, K., Elliott, R.M., 2005. Role of N-linked glycans on bunyamwera
virus glycoproteins in intracellular trafﬁcking, protein folding, and virus
infectivity. J. Virol. 79, 13725–13734.
Shi, X., Elliott, R.M., 2004. Analysis of N-linked glycosylation of hantaan virus
glycoproteins and the role of oligosaccharide side chains in protein folding and
intracellular trafﬁcking. J. Virol. 78, 5414–5422.
Stark, R., Meyers, G., Rumenapf, T., Thiel, H.J., 1993. Processing of pestivirus
polyprotein: cleavage site between autoprotease and nucleocapsid protein of
classical swine fever virus. J. Virol. 67, 7088–7095.
Su, M.W., Lin, H.M., Yuan, H.S., Chu, W.C., 2009. Categorizing host-dependent RNA
viruses by principal component analysis of their codon usage preferences.
J. Comput. Biol. 16, 1539–1547.
Tamura, T., Sakoda, Y., Yoshino, F., Nomura, T., Yamamoto, N., Sato, Y., Okamatsu, M.,
Ruggli, N., Kida, H., 2012. Selection of classical swine fever virus with enhanced
pathogenicity reveals synergistic virulence determinants in E2 and NS4B. J. Virol.
86, 8602–8613.
Tang, F., Zhang, C., 2007. Evidence for positive selection on the E2 gene of bovine
viral diarrhoea virus type 1. Virus Genes 35, 629–634.
Tao, P., Dai, L., Luo, M., Tang, F., Tien, P., Pan, Z., 2009. Analysis of synonymous
codon usage in classical swine fever virus. Virus Genes 38, 104–112.
Tautz, N., Elbers, K., Stoll, D., Meyers, G., Thiel, H.J., 1997. Serine protease of
pestiviruses: determination of cleavage sites. J. Virol. 71, 5415–5422.
Tews, B.A., Schu¨rmann, E.M., Meyers, G., 2009. Mutation of cysteine 171 of
pestivirus E rns RNase prevents homodimer formation and leads to attenua-
tion of classical swine fever virus. J. Virol. 83, 4823–4834.
Thiel, H.J., Stark, R., Weiland, E., Ru¨menapf, T., Meyers, G., 1991. Hog cholera virus:
molecular composition of virions from a pestivirus. J. Virol. 65, 4705–4712.
Tratschin, J.D., Moser, C., Ruggli, N., Hofmann, M.A., 1998. Classical swine fever
virus leader proteinase Npro is not required for viral replication in cell culture.
J. Virol. 72, 7681–7684.
Trombetta, E.S., 2003. The contribution of N-glycans and their processing in
the endoplasmic reticulum to glycoprotein biosynthesis. Glycobiology 13,
77R–91R.
Van Gennip, H.G., Hesselink, A.T., Moormann, R.J., Hulst, M.M., 2005. Dimerisation
of glycoprotein Erns of classical swine fever virus is not essential for viral
replication and infection. Arch. Virol. 150, 2271–2288.
Van Gennip, H.G., Vlot, A.C., Hulst, M.M., de Smit, A.J., Moormann, R.J., 2004.
Determinants of virulence of classical swine fever virus strain Brescia. J. Virol.
78, 8812–8823.
Vandeputte, J., Chappuis, G., 1999. Classical swine fever: the European experience
and a guide for infected areas. Rev. Sci. Tech. 18, 638–647.
Veluraja, K., Suresh, M.X., Christlet, T.H., Raﬁ, Z.A., 2001. Molecular modeling of
sialyloligosaccharide fragments into the active site of inﬂuenza virus N9
neuraminidase. J. Biomol. Struct. Dyn. 19, 33–45.
Wu, Z., Wang, Q., Feng, Q., Liu, Y., Teng, J., Yu, A.C., Chen, J., 2010. Correlation of the
virulence of CSFV with evolutionary patterns of E2 glycoprotein. Front. Biosci.
(Elite Ed) 2, 204–220.
